DHA 17.1 sbir phase II medical r & d contract for proposal #H2-0303, titled "development of a specialized miniature stimulator system for non-opioid pain relief", ERMS18054003
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH18C0329
- Awardee
-
SPR Therapeutics, Inc. UEI LWF1M6NK1Z43
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,527,168
Award facts
- Opportunity
-
- HQ003417R1ADB Solicitation number
- Contract value 100% obligated
- $1,527,167.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Beachwood, OH 44122, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $546,200 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $980,968 |
About this award
This federal contract award, valued at $1,527,167.51, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense to SPR Therapeutics, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract, designated as a Small Business Innovation Research (SBIR) Phase II action, supports the "Development of a Specialized Miniature Stimulator System for Non-Opioid Pain Relief" under proposal #H2-0303. The contract has a total small business set-aside and an ultimate completion date of December 22, 2022. SPR Therapeutics specializes in providing medical devices and equipment, particularly in the field of pain management and neurostimulation, to various federal agencies, including the Department of Veterans Affairs. The company has secured multiple federal contract awards and grants, including a significant Project Grant from the Department of Defense's Defense Health Agency to develop a non-opioid peripheral nerve stimulation system for use by U.S. service members.
Quick answers
Who was awarded contract W81XWH18C0329?
W81XWH18C0329 was awarded to SPR Therapeutics, Inc. by Medical Command (Department of the Army) on September 24, 2018.
How much is contract W81XWH18C0329 worth?
The government has obligated $1,527,168 on W81XWH18C0329.
Was contract W81XWH18C0329 competed?
The extent of competition for W81XWH18C0329 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award